Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Milestone Pharmaceuticals (NASDAQ: MIST) announced its participation in the upcoming Jefferies Healthcare Conference, scheduled for June 3-5, 2025, in New York. The company will be represented by Chief Financial Officer Amit Hasija and Chief Commercial Officer Lorenz Muller. Their presentation is set for June 5th at 8:10 AM EDT.
The presentation will be accessible via webcast and will remain available for replay on Milestone's website for approximately 90 days. Interested parties can find the webcast in the News & Events section at www.milestonepharma.com. Investors seeking meetings with the Milestone team during the conference should contact their Jefferies representative.
Milestone Pharmaceuticals (NASDAQ: MIST) ha annunciato la sua partecipazione al prossimo Jefferies Healthcare Conference, che si terrà dal 3 al 5 giugno 2025 a New York. L'azienda sarà rappresentata dal Chief Financial Officer Amit Hasija e dal Chief Commercial Officer Lorenz Muller. La loro presentazione è programmata per il 5 giugno alle 8:10 AM EDT.
La presentazione sarà accessibile tramite webcast e resterà disponibile per la visione in replica sul sito web di Milestone per circa 90 giorni. Gli interessati potranno trovare il webcast nella sezione News & Events su www.milestonepharma.com. Gli investitori che desiderano fissare incontri con il team di Milestone durante la conferenza sono invitati a contattare il proprio rappresentante Jefferies.
Milestone Pharmaceuticals (NASDAQ: MIST) anunció su participación en la próxima Jefferies Healthcare Conference, programada del 3 al 5 de junio de 2025 en Nueva York. La compañía estará representada por el Director Financiero Amit Hasija y el Director Comercial Lorenz Muller. Su presentación está prevista para el 5 de junio a las 8:10 AM EDT.
La presentación estará disponible vía webcast y podrá verse en repetición en el sitio web de Milestone durante aproximadamente 90 días. Los interesados pueden encontrar el webcast en la sección de Noticias y Eventos en www.milestonepharma.com. Los inversores que deseen concertar reuniones con el equipo de Milestone durante la conferencia deben contactar a su representante de Jefferies.
Milestone Pharmaceuticals (NASDAQ: MIST)는 2025년 6월 3일부터 5일까지 뉴욕에서 열리는 Jefferies Healthcare Conference에 참여한다고 발표했습니다. 회사는 최고재무책임자 Amit Hasija와 최고상업책임자 Lorenz Muller가 대표로 참석할 예정입니다. 발표는 6월 5일 오전 8시 10분(EDT)에 진행됩니다.
발표는 웹캐스트를 통해 시청할 수 있으며, 약 90일간 Milestone 웹사이트에서 다시보기로 제공됩니다. 관심 있는 분들은 www.milestonepharma.com의 뉴스 및 이벤트 섹션에서 웹캐스트를 확인할 수 있습니다. 컨퍼런스 기간 동안 Milestone 팀과의 미팅을 원하는 투자자는 Jefferies 담당자에게 연락하시기 바랍니다.
Milestone Pharmaceuticals (NASDAQ : MIST) a annoncé sa participation à la prochaine Jefferies Healthcare Conference, prévue du 3 au 5 juin 2025 à New York. La société sera représentée par le Directeur Financier Amit Hasija et le Directeur Commercial Lorenz Muller. Leur présentation est programmée pour le 5 juin à 8h10 EDT.
La présentation sera accessible en webcast et restera disponible en replay sur le site de Milestone pendant environ 90 jours. Les personnes intéressées peuvent trouver le webcast dans la section Actualités & Événements sur www.milestonepharma.com. Les investisseurs souhaitant organiser des rencontres avec l'équipe Milestone durant la conférence doivent contacter leur représentant Jefferies.
Milestone Pharmaceuticals (NASDAQ: MIST) gab bekannt, dass es an der bevorstehenden Jefferies Healthcare Conference teilnimmt, die vom 3. bis 5. Juni 2025 in New York stattfindet. Das Unternehmen wird vertreten durch Chief Financial Officer Amit Hasija und Chief Commercial Officer Lorenz Muller. Ihre Präsentation ist für den 5. Juni um 8:10 Uhr EDT angesetzt.
Die Präsentation wird per Webcast zugänglich sein und etwa 90 Tage lang auf der Website von Milestone zur Wiederholung bereitstehen. Interessierte finden den Webcast im Bereich News & Events unter www.milestonepharma.com. Investoren, die während der Konferenz Treffen mit dem Milestone-Team wünschen, sollten ihren Jefferies-Ansprechpartner kontaktieren.
- None.
- None.
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will present at the Jefferies Healthcare Conference, to take place June 3 - 5, 2025, in New York.
A webcast of the presentation will be available on June 5th at 8:10 AM EDT. The webcast will be available to watch live and there will be a replay for approximately 90-days following the presentation on the News & Events section of Milestone's website www.milestonepharma.com.
If you are interested in meeting with the Milestone team during the conference, please reach out to your Jefferies representative.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone's lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat symptomatic episodic attacks associated with PSVT and AFib-RVR.
Contact:
Kim Fox, Vice President, Communications, kfox@milestonepharma.com
Investor Relations
Kevin Gardner, kgardner@lifesciadvisors.com
FAQ
When is Milestone Pharmaceuticals (MIST) presenting at the Jefferies Healthcare Conference 2025?
Who will represent Milestone Pharmaceuticals (MIST) at the Jefferies Healthcare Conference?
How can I watch Milestone Pharmaceuticals' (MIST) presentation at the Jefferies Conference?
How can investors meet with Milestone Pharmaceuticals' (MIST) management at the Jefferies Conference?
